The effect of smoking on the symptoms and progression of multiple sclerosis: a review

References

• CompstonAColesAMultiple sclerosisLancet200837296481502151718970977
   PubMed Web of Science ®Google Scholar
• CompstonAColesAMultiple sclerosisLancet200235993131221123111955556
   PubMed Web of Science ®Google Scholar
• AscherioAMungerKLEnvironmental risk factors for multiple sclerosis. Part II: noninfectious factorsAnn Neurol200761650451317492755
   PubMed Web of Science ®Google Scholar
• NoseworthyJHLucchinettiCRodriguezMWeinshenkerBGMultiple sclerosisN Engl J Med20003431393895211006371
   PubMed Web of Science ®Google Scholar
• MillerDBarkhofFMontalbanXThompsonAFilippiMClinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosisLancet Neurol20054528128815847841
   PubMed Web of Science ®Google Scholar
• FisnikuLKBrexPAAltmannDRDisability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosisBrain2008131Pt 380881718234696
   PubMed Web of Science ®Google Scholar
• LassmannHMechanisms of multiple sclerosisDrug Discov Today Dis Mech200524447452
   Google Scholar
• GranBRostamiAT cells, cytokines, and autoantigens in multiple sclerosisCurr Neurol Neurosci Rep20011326327011898528
   PubMed Web of Science ®Google Scholar
• de StefanoNNarayananSFrancisGSEvidence of axonal damage in the early stages of multiple sclerosis and its relevance to disabilityArch Neurol2001581657011176938
   PubMedGoogle Scholar
• MaggsFGPalaceJThe pathogenesis of multiple sclerosis: is it really a primary inflammatory process?Mult Scler200410332632915222700
   PubMed Web of Science ®Google Scholar
• ConfavreuxCVukusicSAdeleinePEarly clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic processBrain2003126Pt 477078212615637
   PubMed Web of Science ®Google Scholar
• WeinshenkerBGRiceGPNoseworthyJHCarriereWBaskervilleJEbersGCThe natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcomeBrain1991114Pt 2104510562043940
   PubMed Web of Science ®Google Scholar
• TremlettHYousefiMDevonshireVRieckmannPZhaoYImpact of multiple sclerosis relapses on progression diminishes with timeNeurology200973201616162319890070
   PubMed Web of Science ®Google Scholar
• ScalfariANeuhausADegenhardtAThe natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disabilityBrain.2010133Pt 71914192920534650
   PubMed Web of Science ®Google Scholar
• FrischerJMBramowSDal-BiancoAThe relation between inflammation and neurodegeneration in multiple sclerosis brainsBrain2009132Pt 51175118919339255
   PubMed Web of Science ®Google Scholar
• TallantyreECBoLAl-RawashdehOGreater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive diseaseBrain2009132Pt 51190119919420101
   PubMed Web of Science ®Google Scholar
• TrappBDNaveKAMultiple sclerosis: an immune or neurodegenerative disorderAnnu Rev Neurosci20083124726918558855
   PubMed Web of Science ®Google Scholar
• LucchinettiCBruckWParisiJScheithauerBRodriguezMLassmannHHeterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelinationAnn Neurol200047670771710852536
   PubMed Web of Science ®Google Scholar
• BarnettMHPrineasJWRelapsing and remitting multiple sclerosis: pathology of the newly forming lesionAnn Neurol200455445846815048884
   PubMed Web of Science ®Google Scholar
• JhaPAvoidable global cancer deaths and total deaths from smokingNat Rev Cancer20099965566419693096
   PubMed Web of Science ®Google Scholar
• WipfliHSametJMGlobal economic and health benefits of tobacco control: part 1Clin Pharmacol Ther200986326327119536067
   PubMed Web of Science ®Google Scholar
• CostenbaderKHKarlsonEWCigarette smoking and autoimmune disease: what can we learn from epidemiology?Lupus2006151173774517153844
   PubMed Web of Science ®Google Scholar
• BrawarskyPBrooksDRWilberNGertzREJrKlein WalkerDTobacco use among adults with disabilities in MassachusettsTob Control200211Suppl 2ii29ii3312034978
   PubMed Web of Science ®Google Scholar
• MikaeloffYCaridadeGTardieuMSuissaSParental smoking at home and the risk of childhood-onset multiple sclerosis in childrenBrain2007130Pt 102589259517827175
   PubMed Web of Science ®Google Scholar
• World Health OrganizationWomen and the tobacco epidemic: challenges for the 21st centuryWHOCanada2001
   Google Scholar
• OrtonSMHerreraBMYeeIMSex ratio of multiple sclerosis in Canada: a longitudinal studyLancet Neurol200651193293617052660
   PubMed Web of Science ®Google Scholar
• AlonsoAHernanMATemporal trends in the incidence of multiple sclerosis: a systematic reviewNeurology200871212913518606967
   PubMed Web of Science ®Google Scholar
• KeslerAPiankaPToxic optic neuropathyCurr Neurol Neurosci Rep20033541041412914684
   PubMedGoogle Scholar
• CourvilleCBMaschmeyerJEDelayCPEffects of smoking on the acute exacerbations of multiple sclerosisBull Los Angel Neuro Soc1964291614129452
   PubMedGoogle Scholar
• PerkinGDBowdenPCliffordRSmoking and optic neuritisPostgrad Med J1975513823851215251
   PubMed Web of Science ®Google Scholar
• EmreMde DeckerCEffects of cigarette smoking on motor functions in patients with multiple sclerosisArch Neurol19924912124312471449402
   PubMedGoogle Scholar
• SundstromPNystromLSmoking worsens the prognosis in multiple sclerosisMult Scler20081481031103518632778
   PubMed Web of Science ®Google Scholar
• PittasFPonsonbyALvan der MeiIASmoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosisJ Neurol2009256457758519365595
   PubMed Web of Science ®Google Scholar
• HernanMAJickSSLogroscinoGOlekMJAscherioAJickHCigarette smoking and the progression of multiple sclerosisBrain2005128Pt 61461146515758034
   PubMed Web of Science ®Google Scholar
• HealyBCAliENGuttmannCRSmoking and disease progression in multiple sclerosisArch Neurol200966785886419597087
   PubMed Web of Science ®Google Scholar
• ZivadinovRWeinstock-GuttmanBHashmiKSmoking is associated with increased lesion volumes and brain atrophy in multiple sclerosisNeurology200973750451019687451
   PubMed Web of Science ®Google Scholar
• Di PauliFReindlMEhlingRSmoking is a risk factor for early conversion to clinically definite multiple sclerosisMult Scler20081481026103018632775
   PubMed Web of Science ®Google Scholar
• KochMvan HartenAUyttenboogaartMde KeyserJCigarette smoking and progression in multiple sclerosisNeurology200769151515152017923613
   PubMed Web of Science ®Google Scholar
• SoporiMEffects of cigarette smoke on the immune systemNat Rev Immunol20022537237712033743
   PubMed Web of Science ®Google Scholar
• RennardSICigarette smoke in researchAm J Respir Cell Mol Biol200431547948015494467
   PubMed Web of Science ®Google Scholar
• WayJLCyanide intoxication and its mechanism of antagonismAnnu Rev Pharmacol Toxicol1984244514816428300
   PubMed Web of Science ®Google Scholar
• HernanMAOlekMJAscherioACigarette smoking and incidence of multiple sclerosisAm J Epidemiol20011541697411427406
   PubMed Web of Science ®Google Scholar
• HicksSPBrain metabolism in vivo; the distribution of lesions caused by cyanide poisoning, insulin hypoglycemia, asphyxia in nitrogen and fluoroacetate poisoning in ratsAMA Arch Pathol1950492111137
   Google Scholar
• IbrahimMZBriscoePBJrBaylissOBAdamsCWThe relationship between enzyme activity and neuroglia in the prodromal and demyelinating stages of cyanide encephalopathy in the ratJ Neurol Neurosurg Psychiatry19632647948614083218
   PubMed Web of Science ®Google Scholar
• LevineSGeibLWLeukoencephalopathy in a cat due to accidental cyanide poisoningPathol Vet1966331901956006229
   PubMedGoogle Scholar
• LevineSStypulkowskiWExperimental cyanide encephalopathyAMA Arch Pathol1959673306323
   Google Scholar
• LevineSWenkEJCyanide encephalopathy produced by intravenous routeJ Nerv Ment Dis195912930230514416288
   PubMed Web of Science ®Google Scholar
• LumsdenCECyanide leukoencephalopathy in rats and observations on the vascular and ferment hypotheses of demyelinating diseasesJ Neurol Neurosurg Psychiatry195013111515405306
   PubMed Web of Science ®Google Scholar
• van HoutenWHFriedeRLHistochemical studies of experimental demyelination produced with cyanideExp Neurol1961440241213924587
   PubMed Web of Science ®Google Scholar
• HurstEWExperimental demyelination in relation to human and animal diseaseAm J Med195212554756014933430
   PubMed Web of Science ®Google Scholar
• LevineSExperimental cyanide encephalopathy: gradients of susceptibility in the corpus callosumJ Neuropathol Exp Neurol19672622142226022169
   PubMed Web of Science ®Google Scholar
• EvangelouNKonzDEsiriMMSmithSPalaceJMatthewsPMRegional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosisBrain2000123Pt 91845184910960048
   PubMed Web of Science ®Google Scholar
• MinagarAAlexanderJSBlood-brain barrier disruption in multiple sclerosisMult Scler20039654054914664465
   PubMed Web of Science ®Google Scholar
• HansFJWeiLBereczkiDNicotine increases microvascular blood flow and flow velocity in three groups of brain areasAm J Physiol19932656 Pt 2H214221508285254
   PubMedGoogle Scholar
• GrunwaldFSchrockHKuschinskyWThe influence of nicotine on local cerebral blood flow in ratsNeurosci Lett199112411081101857536
   PubMed Web of Science ®Google Scholar
• ChenJLWeiLBereczkiDNicotine raises the influx of permeable solutes across the rat blood-brain barrier with little or no capillary recruitmentJ Cereb Blood Flow Metab19951546876987790419
   PubMed Web of Science ®Google Scholar
• HawkinsBTAbbruscatoTJEgletonRDNicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distributionBrain Res200410271–2485815494156
   PubMed Web of Science ®Google Scholar
• HedstromAKBaarnhielmMOlssonTAlfredssonLTobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosisNeurology200973969670119720976
   PubMed Web of Science ®Google Scholar
• SoporiMLKozakWImmunomodulatory effects of cigarette smokeJ Neuroimmunol1998831–21481569610683
   PubMed Web of Science ®Google Scholar
• FlotoRASmithKGThe vagus nerve, macrophages, and nicotineLancet200336193631069107012672307
   PubMed Web of Science ®Google Scholar
• GuinetEYoshidaKNouri-ShiraziMNicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs)Immunol Lett2004951455515325797
   PubMed Web of Science ®Google Scholar
• Nouri-ShiraziMTinajeroRGuinetENicotine alters the biological activities of developing mouse bone marrow-derived dendritic cells (DCs)Immunol Lett2007109215516417368810
   PubMed Web of Science ®Google Scholar
• FrancusTKleinRFStaiano-CoicoLBeckerCGSiskindGWEffects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cellsJ Immunol19881406182318293257988
   PubMed Web of Science ®Google Scholar
• ShiFDPiaoWHKuoYPCampagnoloDIVollmerTLLukasRJNicotinic attenuation of central nervous system inflammation and autoimmunityJ Immunol200918231730173919155522
   PubMed Web of Science ®Google Scholar
• BijlMHorstGLimburgPCKallenbergCGEffects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytesEur J Clin Invest200131655055311422406
   PubMed Web of Science ®Google Scholar
• GraeveLBaumannMHeinrichPCInterleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defenseClin Investig1993718664671
   Google Scholar
• SzalaiAJC-reactive protein (CRP) and autoimmune disease: facts and conjecturesClin Dev Immunol2004113–422122615559367
   PubMedGoogle Scholar
• IngramGHakobyanSRobertsonNPMorganBPComplement in multiple sclerosis: its role in disease and potential as a biomarkerClin Exp Immunol2009155212813919040603
   PubMed Web of Science ®Google Scholar
• LumsdenCEThe immunogenesis of the multiple sclerosis plaqueBrain Res19712833653904939243
   PubMed Web of Science ®Google Scholar
• TeglaCACudriciCRusVNeuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survivalJ Neuroimmunol20092131–231119577811
   PubMed Web of Science ®Google Scholar
• RobbinsRANelsonKJGossmanGLKoyamaSRennardSIComplement activation by cigarette smokeAm J Physiol19912604 Pt 1L2542591902064
   PubMed Web of Science ®Google Scholar
• VolanakisJEKaplanMHInteraction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1qJ Immunol197411319174208926
   PubMed Web of Science ®Google Scholar
• EncinasJMManganasLEnikolopovGNitric oxide and multiple sclerosisCurr Neurol Neurosci Rep20055323223815865889
   PubMedGoogle Scholar
• ClancyRMAminARAbramsonSBThe role of nitric oxide in inflammation and immunityArthritis Rheum1998417114111519663469
   PubMed Web of Science ®Google Scholar
• SmithKJKapoorRHallSMDaviesMElectrically active axons degenerate when exposed to nitric oxideAnn Neurol200149447047611310624
   PubMed Web of Science ®Google Scholar
• RedfordEJKapoorRSmithKJNitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptibleBrain1997120Pt 12214921579448570
   PubMed Web of Science ®Google Scholar
• KapoorRDaviesMBlakerPAHallSMSmithKJBlockers of sodium and calcium entry protect axons from nitric oxide-mediated degenerationAnn Neurol200353217418012557283
   PubMed Web of Science ®Google Scholar
• OleszakELZaczynskaEBhattacharjeeMButunoiCLegidoAKatsetosCDInducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosisClin Diagn Lab Immunol1998544384459665945
   PubMedGoogle Scholar
• LiuJSZhaoMLBrosnanCFLeeSCExpression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesionsAm J Pathol200115862057206611395383
   PubMed Web of Science ®Google Scholar
• RejdakKEikelenboomMJPetzoldACSF nitric oxide metabolites are associated with activity and progression of multiple sclerosisNeurology20046381439144515505162
   PubMed Web of Science ®Google Scholar
• ChurchDFPryorWAFree-radical chemistry of cigarette smoke and its toxicological implicationsEnviron Health Perspect1985641111263007083
   PubMed Web of Science ®Google Scholar
• SarkarRGelabertHAMohiuddinKRThakorDKSantibanez-GalleraniASEffect of cigarette smoke on endothelial regeneration in vivo and nitric oxide levelsJ Surg Res1999821434710068524
   PubMed Web of Science ®Google Scholar
• MillerVMLewisDARudKSOffordKPCroghanITHurtRDPlasma nitric oxide before and after smoking cessation with nicotine nasal sprayJ Clin Pharmacol199838122279597555
   PubMed Web of Science ®Google Scholar
• ZhouJFYanXFGuoFZSunNYQianZJDingDYEffects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stressBiomed Environ Sci2000131445510853840
   PubMed Web of Science ®Google Scholar
• NodeKKitakazeMYoshikawaHKosakaHHoriMReversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adultsAm J Cardiol19977911153815419185651
   PubMed Web of Science ®Google Scholar
• GrahamNMThe epidemiology of acute respiratory infections in children and adults: a global perspectiveEpidemiol Rev1990121491782286216
   PubMed Web of Science ®Google Scholar
• SibleyWABamfordCRClarkKClinical viral infections and multiple sclerosisLancet19853258441131313152860501
   PubMed Web of Science ®Google Scholar
• AndersenOLygnerPEBergstromTAnderssonMVahlneAViral infections trigger multiple sclerosis relapses: a prospective seroepide-miological studyJ Neurol199324074174228410082
   PubMed Web of Science ®Google Scholar
• PanitchHSInfluence of infection on exacerbations of multiple sclerosisAnn Neurol199436SupplS25288017885
   PubMed Web of Science ®Google Scholar
• EdwardsSZvartauMClarkeHIrvingWBlumhardtLDClinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosisJ Neurol Neurosurg Psychiatry19986467367419647301
   PubMed Web of Science ®Google Scholar
• BuljevacDFlachHZHopWCProspective study on the relationship between infections and multiple sclerosis exacerbationsBrain2002125Pt 595296011960885
   PubMed Web of Science ®Google Scholar
• SriramSStrattonCWYaoSChlamydia pneumoniae infection of the central nervous system in multiple sclerosisAnn Neurol199946161410401775
   PubMed Web of Science ®Google Scholar
• ParrattJTavendaleRO’RiordanJParrattDSwinglerRChlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosisMult Scler200814329229918208884
   PubMed Web of Science ®Google Scholar
• BudakFKeceliSEfendiHVahabogluHThe investigation of Chlamydophila pneumoniae in patients with multiple sclerosisInt J Neurosci2007117340941517365124
   PubMed Web of Science ®Google Scholar
• BomanJRoblinPMSundstromPSandstromMHammerschlagMRFailure to detect Chlamydia pneumoniae in the central nervous system of patients with MSNeurology.200054126510636169
   PubMed Web of Science ®Google Scholar
• KarvonenMTuomilehtoJPitkaniemiJNaukkarinenASaikkuPImportance of smoking for Chlamydia pneumoniae seropositivityInt J Epidemiol1994236131513217721536
   PubMed Web of Science ®Google Scholar
• RidkerPMKundsinRBStampferMJPoulinSHennekensCHProspective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarctionCirculation19999991161116410069783
   PubMed Web of Science ®Google Scholar
• AscherioAMungerKLEnvironmental risk factors for multiple sclerosis. Part I: the role of infectionAnn Neurol200761428829917444504
   PubMed Web of Science ®Google Scholar
• NielsenTRPedersenMRostgaardKFrischMHjalgrimHCorrelations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individualsMult Scler200713342042317439912
   PubMed Web of Science ®Google Scholar
• FarrellRAAntonyDWallGRHumoral immune response to EBV in multiple sclerosis is associated with disease activity on MRINeurology2009731323819458321
   PubMed Web of Science ®Google Scholar
• RosenbergGAMatrix metalloproteinases biomarkers in multiple sclerosisLancet200536594671291129315823367
   PubMed Web of Science ®Google Scholar
• LeeMAPalaceJStablerGFordJGearingAMillerKSerum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI studyBrain1999122Pt 219119710071048
   PubMed Web of Science ®Google Scholar
• NakamuraTEbiharaIShimadaNKoideHEffect of cigarette smoking on plasma metalloproteinase-9 concentrationClin Chim Acta199827621731779764735
   PubMed Web of Science ®Google Scholar
• SfagosCMakisACChaidosASerum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patientsMult Scler200511327227515957506
   PubMed Web of Science ®Google Scholar
• Abo-KryshaNRashedLThe role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian studyMult Scler200814560260818408021
   PubMed Web of Science ®Google Scholar
• GutteridgeJMIron and oxygen radicals in brainAnn Neurol199232SupplS16211510375
   PubMed Web of Science ®Google Scholar
• HalliwellBGutteridgeJMOxygen toxicity, oxygen radicals, transition metals and diseaseBiochem J198421911146326753
   PubMed Web of Science ®Google Scholar
• BorgDCTarrMSamsonFOxygen free radicals and tissue injury. A reference outlineOxygen Free Radicals in Tissue DamageBostonBirkhauser19931253
   Google Scholar
• BorgDCSchaichKMIron and iron-derived radicalsHalliwellBOxygen Radicals and Tissue InjuryBethesda, MDFederation of American Societies for Experimental Biology19982026
   Google Scholar
• El-ZayadiARSelimOHamdyHEl-TawilAMoustafaHHeavy cigarette smoking induces hypoxic polycythemia (erythrocytosis) and hyperuricemia in chronic hepatitis C patients with reversal of clinical symptoms and laboratory parameters with therapeutic phlebotomyAm J Gastroenterol20029751264126512014742
   PubMed Web of Science ®Google Scholar
• PadmavathiPReddyVDVaradacharyuluNInfluence of chronic cigarette smoking on serum biochemical profile in male human volunteersJ Health Sci2009552265270
   Google Scholar
• BernhardDRossmannAWickGMetals in cigarette smokeIUBMB Life2005571280580916393783
   PubMed Web of Science ®Google Scholar
• SuzukiTShishidoSUrushiyamaKMercury in cigarettesTohoku J Exp Med19761194353356960100
   PubMed Web of Science ®Google Scholar
• KrigmanMRNeuropathology of heavy metal intoxicationEnviron Health Perspect197826117120363412
   PubMed Web of Science ®Google Scholar
• DringenRBishopGMKoeppeMDangTNRobinsonSRThe pivotal role of astrocytes in the metabolism of iron in the brainNeurochem Res200732111884189017551833
   PubMed Web of Science ®Google Scholar
• Tiffany-CastiglionEQianYAstroglia as metal depots: molecular mechanisms for metal accumulation, storage and releaseNeurotoxicology200122557759211770879
   PubMed Web of Science ®Google Scholar
• ValbergLSFlanaganPRKerteszAEbersGCAbnormalities in iron metabolism in multiple sclerosisCan J Neurol Sci19891621841862731085
   PubMed Web of Science ®Google Scholar
• HaackeEMChengNYHouseMJImaging iron stores in the brain using magnetic resonance imagingMagn Reson Imaging200523112515733784
   PubMed Web of Science ®Google Scholar
• ToshniwalPKZarlingEJEvidence for increased lipid peroxidation in multiple sclerosisNeurochem Res19921722052071538834
   PubMed Web of Science ®Google Scholar
• LeVineSMIron deposits in multiple sclerosis and Alzheimer’s disease brainsBrain Res19977601–22983039237552
   PubMed Web of Science ®Google Scholar
• KermodeAGThompsonAJToftsPBreakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implicationsBrain.1990113Pt 5147714892245307
   PubMed Web of Science ®Google Scholar
• TanILvan SchijndelRAPouwelsPJMR venography of multiple sclerosisAJNR Am J Neuroradiol20002161039104210871010
   PubMed Web of Science ®Google Scholar
• ZamboniPGaleottiRMenegattiEChronic cerebrospinal venous insufficiency in patients with multiple sclerosisJ Neurol Neurosurg Psychiatry200980439239919060024
   PubMed Web of Science ®Google Scholar
• ZamboniPThe big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosisJ R Soc Med2006991158959317082306
   PubMed Web of Science ®Google Scholar
• ZamboniPMenegattiEGaleottiRThe value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosisJ Neurol Sci20092821–2212719144359
   PubMed Web of Science ®Google Scholar
• ZivadinovRMarrKRamanathanMCombined transcranial and extracranial venous doppler evaluation (CTEVD Study). Description of the design and interim results of an epidemiological study of the prevalence of chronic cerebrospinal venous insufficiency in MS and related diseasesNeurology.201074Suppl 2A545
   Google Scholar
• GourgouSDedieuFSancho-GarnierHLower limb venous insufficiency and tobacco smoking: a case-control studyAm J Epidemiol2002155111007101512034579
   PubMed Web of Science ®Google Scholar
• HickeyRJClellandRCBoyceDECarbon monoxide: smoking, air pollution, cardiovascular disease, and physiological homoeostasisLancet1973278285715724125339
   PubMed Web of Science ®Google Scholar
• MichielsCArnouldTRemacleJHypoxia-induced activation of endothelial cells as a possible cause of venous diseases: hypothesisAngiology19934486396468342881
   PubMed Web of Science ®Google Scholar
• HigmanDJPowellJTGreenhalghRMCoadyAMossJIs thickening of the basal lamina in the saphenous vein a hallmark of smoking?Br Heart J199471145508297694
   PubMedGoogle Scholar
• HigmanDJGreenhalghRMPowellJTSmoking impairs endothelium-dependent relaxation of saphenous veinBr J Surg19938010124212458242287
   PubMed Web of Science ®Google Scholar
• LeeABLaredoJNevilleREmbryological background of truncular venous malformation in the extracranial venous pathways as the cause of chronic cerebro spinal venous insufficiencyInt Angiol20102929510820351665
   PubMed Web of Science ®Google Scholar
• MyhrKMVitamin D treatment in multiple sclerosisJ Neurol Sci20092861–210410819549608
   PubMed Web of Science ®Google Scholar
• MorabiaABernsteinMSAntoniniSSmoking, dietary calcium and vitamin D deficiency in women: a population-based studyEur J Clin Nutr200054968468911002379
   PubMed Web of Science ®Google Scholar
• BrotCJorgensenNRSorensenOHThe influence of smoking on vitamin D status and calcium metabolismEur J Clin Nutr1999531292092610602348
   PubMed Web of Science ®Google Scholar
• TremlettHvan der MeiIAPittasFMonthly ambient sunlight, infections and relapse rates in multiple sclerosisNeuroepidemiology200831427127918971584
   PubMed Web of Science ®Google Scholar
• IstvanJMatarazzoJDTobacco, alcohol, and caffeine use: a review of their interrelationshipsPsychol Bull19849523013266544436
   PubMed Web of Science ®Google Scholar
• TangJMuirJLancasterTJonesLFowlerGHealth profiles of current and former smokers and lifelong abstainersOXCHECK Study GroupOXfordand Collaborators HEalth ChecKJ R Coll Physicians Lond1997313304309
   Google Scholar
• TolaMRGranieriEMalaguSDietary habits and multiple sclerosis. A retrospective study in Ferrara, ItalyActa Neurol (Napoli)19941641891977856473
   PubMedGoogle Scholar
• PekmezovicTDrulovicJMilenkovicMLifestyle factors and multiple sclerosis: a case-control study in BelgradeNeuroepidemiology200627421221617095875
   PubMed Web of Science ®Google Scholar
• GoodinDSSurvey of multiple sclerosis in northern California. Northern California MS Study GroupMult Scler199952788810335515
   PubMed Web of Science ®Google Scholar
• PrakashRSSnookEMEricksonKICardiorespiratory fitness: a predictor of cortical plasticity in multiple sclerosisNeuroimage20073431238124417134916
   PubMed Web of Science ®Google Scholar
• CadeJEMargettsBMRelationship between diet and smoking – is the diet of smokers different?J Epidemiol Community Health19914542702721795144
   PubMed Web of Science ®Google Scholar
• ZhangSMWillettWCHernanMAOlekMJAscherioADietary fat in relation to risk of multiple sclerosis among two large cohorts of womenAm J Epidemiol2000152111056106411117615
   PubMed Web of Science ®Google Scholar
• FarinottiMSimiSDi PietrantonjCDietary interventions for multiple sclerosisCochrane Database Syst Rev20071CD00419217253500
   PubMed Web of Science ®Google Scholar
• ZhangSMHernanMAOlekMJSpiegelmanDWillettWCAscherioAIntakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of womenNeurology2001571758011445631
   PubMed Web of Science ®Google Scholar
• BamiaCTrichopoulouALenasDTrichopoulosDTobacco smoking in relation to body fat mass and distribution in a general population sampleInt J Obes Relat Metab Disord20042881091109615197410
   PubMed Web of Science ®Google Scholar
• MungerKLChitnisTAscherioABody size and risk of MS in two cohorts of US womenNeurology200973191543155019901245
   PubMed Web of Science ®Google Scholar
• FergussonDMLynskeyMTHorwoodLJComorbidity between depressive disorders and nicotine dependence in a cohort of 16-year-oldsArch Gen Psychiatry19965311104310478911227
   PubMed Web of Science ®Google Scholar
• SiegertRJAbernethyDADepression in multiple sclerosis: a reviewJ Neurol Neurosurg Psychiatry200576446947515774430
   PubMed Web of Science ®Google Scholar
• MarrieRAHorwitzRCutterGTyryTCampagnoloDVollmerTComorbidity delays diagnosis and increases disability at diagnosis in MSNeurology200972211712418971448
   PubMed Web of Science ®Google Scholar
• MarrieRARudickRHorwitzRVascular comorbidity is associated with more rapid disability progression in multiple sclerosisNeurology201074131041104720350978
   PubMed Web of Science ®Google Scholar
• LynchJRTangWWangHAPOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory responseJ Biol Chem200327849485294853314507923
   PubMed Web of Science ®Google Scholar
• SenaACoudercRFerret-SenaVApolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosisEur J Neurol200916783283719473356
   PubMed Web of Science ®Google Scholar
• ReitzCden HeijerTvan DuijnCHofmanABretelerMMRelation between smoking and risk of dementia and Alzheimer disease: the Rotterdam StudyNeurology20076910998100517785668
   PubMed Web of Science ®Google Scholar
• SinghRBardenAMoriTBeilinLAdvanced glycation end-products: a reviewDiabetologia200144212914611270668
   PubMed Web of Science ®Google Scholar
• GoldinABeckmanJASchmidtAMCreagerMAAdvanced glycation end products: sparking the development of diabetic vascular injuryCirculation2006114659760516894049
   PubMed Web of Science ®Google Scholar
• HofmannMADrurySFuCRAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptidesCell199997788990110399917
   PubMed Web of Science ®Google Scholar
• SchmidtAMYanSDYanSFSternDMThe multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responsesJ Clin Invest2001108794995511581294
   PubMed Web of Science ®Google Scholar
• SternbergZWeinstock-GuttmanBHojnackiDSoluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severityMult Scler200814675976318505774
   PubMed Web of Science ®Google Scholar
• YanSSWuZYZhangHPSuppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous systemNat Med20039328729312598893
   PubMed Web of Science ®Google Scholar
• VazzanaNSantilliFCuccurulloCDaviGSoluble forms of RAGE in internal medicineIntern Emerg Med20094538940119727582
   PubMed Web of Science ®Google Scholar
• CeramiCFoundsHNichollITobacco smoke is a source of toxic reactive glycation productsProc Natl Acad Sci U S A1997942513915139209391127
   PubMed Web of Science ®Google Scholar